This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Department of Health, Ministry of Public Health, Thailand . The reproductive health survey. [online] 2009. [cited 2015 Jul 19]. Available from: http://rh.anamai.moph.go.th/all_file/index/RH.pdfDepartment of Health, Ministry of Public Health, Thailand . The reproductive health survey. [online] 2009. [cited 2015 Jul 19]Available fromhttp://rh.anamai.moph.go.th/all_file/index/RH.pdfSearch in Google Scholar
Stubblefield PG, Roncari DM. Family planning. In: Berek JS, editor. Berek and Novak’s Gynecology, 15th ed. Philadelphia: Lippincott Williams and Wilkins, Wolters Kluwer Health; 2012. p. 211-69.StubblefieldPGRoncariDM.Family planningInBerekJSBerek and Novak’s Gynecology15thPhiladelphiaLippincott Williams and Wilkins, Wolters Kluwer Health201221169Search in Google Scholar
Emans SJ, Grace E, Woods ER, Smith DE, Klein K, Merola J. Adolescents’ compliance with the use of oral contraceptives. JAMA. 1987; 257:3377-81.10.1001/jama.1987.03390240083028EmansSJGraceEWoodsERSmithDEKleinKMerolaJ.Adolescents’ compliance with the use of oral contraceptivesJAMA1987257337781Open DOISearch in Google Scholar
Panyawaranan P, Santibenchakul S, Jaisamrarn U. Compliance of different contraceptive methods in Thai women. Thai J Obstet Gynecol. 2015; 23:130-8.PanyawarananPSantibenchakulSJaisamrarnU.Compliance of different contraceptive methods in Thai womenThai J Obstet Gynecol2015231308Search in Google Scholar
Dieben TO, Roumen FJ, Apter D. Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring. Obstet Gynecol. 2002; 100: 585-93.12220783DiebenTORoumenFJApterD.Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ringObstet Gynecol20021005859310.1097/00006250-200209000-00030Search in Google Scholar
NuvaRing (For U.S. Health Care Professionals). [online] 2015. [cited 2015 Jul 27]. Available from: http://www.merck.com/product/usa/pi_circulars/n/nuvaring/nuvaring_pi.pdfNuvaRing (For U.S. Health Care Professionals). [online] 2015. [cited 2015 Jul 27]Available fromhttp://www.merck.com/product/usa/pi_circulars/n/nuvaring/nuvaring_pi.pdfSearch in Google Scholar
Killick S. Complete and robust ovulation inhibition with NuvaRing. Eur J Contracept Reprod Health Care. 2002;7 (Suppl 2):13-8; discussion 37-9.12659397KillickS.Complete and robust ovulation inhibition with NuvaRingEur J Contracept Reprod Health Care20027(Suppl 2)138discussion 37-910.1080/13625187.2002.1194933029243954Search in Google Scholar
Roumen FJ, Apter D, Mulders TM, Dieben TO. Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol. Hum Reprod. 2001; 16:469-75.10.1093/humrep/16.3.46911228213RoumenFJApterDMuldersTMDiebenTOEfficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiolHum Reprod2001164697511228213Open DOISearch in Google Scholar
Roumen F. Contraceptive efficacy and tolerability with a novel combined contraceptive vaginal ring, NuvaRing. Eur J Contracept Reprod Health Care. 2002; 7 (Suppl 2):19-24; discussion 37-9.12659398RoumenF.Contraceptive efficacy and tolerability with a novel combined contraceptive vaginal ring, NuvaRingEur J Contracept Reprod Health Care20027(Suppl 2)1924discussion 37-910.1080/13625187.2002.1194933129243953Search in Google Scholar
Cagnacci A, Ferrari S, Tirelli A, Zanin R, Volpe A. Route of administration of contraceptives containing desogestrel/etonorgestrel and insulin sensitivity: a prospective randomized study. Contraception. 2009; 80:34-9.10.1016/j.contraception.2009.01.01219501213CagnacciAFerrariSTirelliAZaninRVolpeA.Route of administration of contraceptives containing desogestrel/etonorgestrel and insulin sensitivity: a prospective randomized studyContraception20098034919501213Open DOISearch in Google Scholar
Nguyen BT, Jensen JT. Evaluating the efficacy and safety of a progestin- and estrogen-releasing ethylene vinyl acetate copolymer contraceptive vaginal ring. Expert Opin Drug Saf. 2014; 13:1423-30.10.1517/14740338.2014.94884225106828NguyenBTJensenJT.Evaluating the efficacy and safety of a progestin- and estrogen-releasing ethylene vinyl acetate copolymer contraceptive vaginal ringExpert Opin Drug Saf20141314233025106828Open DOISearch in Google Scholar
Pandit SN, Chauhan AR, Anagani M, Reddy S, Birla A, Ray SK. Multicenter study of contraceptive vaginal ring (NuvaRing®) in normal daily practice in Indian women. J Obstet Gynaecol India. 2014; 64: 409-16.10.1007/s13224-014-0559-725489144PanditSNChauhanARAnaganiMReddySBirlaARaySK.Multicenter study of contraceptive vaginal ring (NuvaRing®) in normal daily practice in Indian womenJ Obstet Gynaecol India20146440916425792125489144Open DOISearch in Google Scholar
Department of Reproductive Health WHO. Medical eligibility criteria for contraceptive use. [online] 2009. [cited 2015 Apr 16]. Available from: http://www.who.int/reproductivehealth/publications/family_planning/Ex-Summ-MEC-5/enDepartment of Reproductive Health WHO. Medical eligibility criteria for contraceptive use. [online] 2009. [cited 2015 Apr 16]Available fromhttp://www.who.int/reproductivehealth/publications/family_planning/Ex-Summ-MEC-5/enSearch in Google Scholar
Bruni V, Pontello V, Luisi S, Petraglia F. An open-label, multicentre trial to evaluate the vaginal bleeding pattern of the combined contraceptive vaginal ring NuvaRing. Eur J Obstet Gynecol Reprod Biol. 2008; 139:65-71.1835858610.1016/j.ejogrb.2008.02.001BruniVPontelloVLuisiSPetragliaF.An open-label, multicentre trial to evaluate the vaginal bleeding pattern of the combined contraceptive vaginal ring NuvaRingEur J Obstet Gynecol Reprod Biol2008139657118358586Search in Google Scholar
Bjarnadottir RI, Tuppurainen M, Killick SR. Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel/ ethinyl estradiol. Am J Obstet Gynecol. 2002; 186: 389-95.10.1067/mob.2002.12110311904596BjarnadottirRITuppurainenMKillickSR.Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel/ ethinyl estradiolAm J Obstet Gynecol20021863899511904596Open DOISearch in Google Scholar
Timmer CJ, Mulders TM. Pharmacokinetics of etonogestrel and ethinylestradiol released from a combined contraceptive vaginal ring. Clin Pharmacokinet. 2000; 39:233-42.10.2165/00003088-200039030-0000511020137TimmerCJMuldersTM.Pharmacokinetics of etonogestrel and ethinylestradiol released from a combined contraceptive vaginal ringClin Pharmacokinet2000392334211020137Open DOISearch in Google Scholar
Oddsson K, Leifels-Fischer B, de Melo NR, Wiel-Masson D, Benedetto C, Verhoeven CH, et al. Efficacy and safety of a contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive: a 1-year randomized trial. Contraception. 2005; 71:176-82.10.1016/j.contraception.2004.09.00115722066OddssonKLeifels-FischerBde MeloNRWiel-MassonDBenedettoCVerhoevenCHet alEfficacy and safety of a contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive: a 1-year randomized trialContraception2005711768215722066Open DOISearch in Google Scholar
Ahrendt HJ, Nisand I, Bastianelli C, Gomez MA, Gemzell-Danielsson K, Urdl W, et al. Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone. Contraception. 2006; 74: 451-7.10.1016/j.contraception.2006.07.00417157101AhrendtHJNisandIBastianelliCGomezMAGemzell-DanielssonKUrdlWet alEfficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenoneContraception200674451717157101Open DOISearch in Google Scholar
Sarkar NN. The combined contraceptive vaginal device (NuvaRing): a comprehensive review. Eur J Contracept Reprod Health Care. 2005; 10:73-8.10.1080/1362518050013168316147810SarkarNN.The combined contraceptive vaginal device (NuvaRing): a comprehensive reviewEur J Contracept Reprod Health Care20051073816147810Open DOISearch in Google Scholar
